Search Results - "Ortiz Gamiz, A."

Assessment of the psychometric properties of the Spanish language version of questionnaire ICIQ-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) by Castro-Díaz, D M, Esteban-Fuertes, M, Salinas-Casado, J, Bustamante-Alarma, S, Gago-Ramos, J L, Galacho-Bech, A, García-Matres, M J, Rodríguez-Toves, L A, Zubiaur-Líbano, C, Collado-Serra, A, Batista-Miranda, J E, Ortiz-Gámiz, A

“…To evaluate the psychometric properties of the Spanish version of the ICIQ-Male Lower Urinary Tract Symptoms Questionnaire (ICIQ-MLUTS): Feasibility (% of…”
Get more information

Assessment of the psychometric properties of the Spanish language version of questionnaire ICIQ-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) by Castro-Díaz, D.M, Esteban-Fuertes, M, Salinas-Casado, J, Bustamante-Alarma, S, Gago-Ramos, J.L, Galacho-Bech, A, García-Matres, M.J, Rodríguez-Toves, L.A, Zubiaur-Líbano, C, Collado-Serra, A, Batista-Miranda, J.E, Ortiz-Gámiz, A

“…Abstract Objectives To evaluate the psychometric properties of the Spanish version of the ICIQ-Male Lower Urinary Tract Symptoms Questionnaire (ICIQ-MLUTS):…”
Get full text

Randomized prospective study comparing BCG and BCG plus oral tegafur in the prevention of stage T1 superficial tumors of the bladder. Results after 2.5 years by Moyano Calvo, J L, Romero Díaz, J A, Ortiz Gamiz, A, Martínez Morán, A, Zerpa Railey, J J, Castiñeiras Fernández, J

“…We present our experience in eighty patients with superficial bladder cancer stage T1. They have been randomized to receive BCG 27 mg weekly x 6 and monthly…”
Get more information

DNA ploidy determination with flow cytometry, Ki-67 index, and overexpression of p53 protein in 121 T1 superficial bladder carcinoma. Retrospective study. Correlation with classic variables by Moyano Calvo, J L, de Miguel Rodríguez, M, Ortiz Gamiz, A, Poyato Galán, J M, Sánchez Sánchez, E, Blanco Palenciano, E, Arribas Rodríguez, J M, Galera Davidson, H, Castiñeiras Fernández, J

“…Observe the correlation between Ki-67 label index, p53 expression and flow cytometry-DNA ploidy with the classic variables (grade, lymphatic permeation,…”
Get more information

The BTA test in the diagnosis of bladder tumors. Usefulness in the hospital setting by Moyano Calvo, J L, Ortiz Gamiz, A, Romero Díaz, J A, Martínez Moran, A, Zerpa Railey, J J, Castiñeiras Fernandez, J

“…We show our results in the diagnostic and follow-up of the bladder tumors comparing de BTA test with Void Cytology, in order to substitute this with the…”
Get more information

ABILITY OF SERUM MARKERS TO DETECT BONE METASTASES IN PATIENTS WITH PROSTATE CANCER by Sánchez Sánchez, E., Ponce, C., Ortiz Gamiz, A., Arribas, J.M., Alvarez Ossorio, J.L., Moyano Calvo, J.L., Castiñeiras Fernández, J.

Get full text

Permeación linfática de la pared vesical en el carcinoma superficial de vejiga T1: Valor pronóstico by Moyano Calvo, J.L., Ortiz Gámiz, A., Poyato Galán, J.M., Gutiérrez González, M., Sánchez Sánchez, E., Álvarez-Ossorio Fernández, J.L., Castiñeiras Fernández, J.

Get full text

Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value by Moyano Calvo, J L, Ortiz Gámiz, A, Poyato Galán, J M, Gutiérrez González, M, Sánchez Sánchez, E, Alvarez-Ossorio Fernández, J L, Castiñeiras Fernández, J

“…It is not usual to use as prognostic factor the bladder lymphatic vessels invasion. 519 T1 bladder tumors with complete resection and follow up of one year at…”
Get full text

DNA ploidy determination with flow cytometry, Ki-67 index and overexpression of p53 protein in 121 T1 superficial bladder carcinomas. Retrospective studies. Part II: Prognostic value and usefulness in the indication for prophylactic treatment with BCG by Moyano Calvo, J L, De Miguel Rodríguez, M, Poyato Galán, J M, Ortíz Gamiz, A, Molina Carranza, A, Zerpa Railey, J J, Toro Cepeda, H, Sánchez-Barriga Peña, D, Galera Davidson, H, Castiñeiras Fernández, J

“…Evaluate the utility of Ki-67 label index, p53 expression and flow cytometry-DNA ploidy in the selection of groups to be treated with prophylactic BCG and the…”
Get more information

The prognostic factors in T1 superficial bladder carcinoma. Our experience by Moyano Calvo, J L, Romero Díaz, A, Ortíz Gamiz, A, Sánchez Sánchez, E, Blanco Palenciano, E, Arribas Rodríguez, J M, Castiñeiras Fernández, J

“…To identify the prognostic factors for recurrence and disease progression in T1 superficial carcinoma of the bladder for prophylactic therapeutic planning. Of…”
Get more information

Histologic-ultrasonographic correlation of gland asymmetry and "pseudoruptures" of the prostatic capsule by Castiñeiras Fernández, J, Romero Díaz, A, Ortiz Gámiz, A, Moyano Calvo, J L, Juárez Soto, A, Sánchez Sánchez, E, Alvarez-Ossorio Fernández, J L, García Cabanillas, M J

“…An histo-ultrasound correlation was carried out between the information obtained with pre-operative transrectal ultrasound and that obtained with the…”
Get more information

C.F.C.-type ureterosigmoidostomy. Results by Castiñeiras Fernández, J, Camacho González, J E, Sánchez-Ferragut, C, Ortiz Gámiz, A, García-Cabanillas, M J, Osman Aga, G, Juárez Soto, A, Soto Delgado, M

“…This paper presents the results obtained with a C.F.C. type ureterosygmoidostomy technique described by us. A total of 25 patients aged between 52 and 74 years…”
Get more information

Permeación linfática de la pared vesical en el carcinoma superficial de vejiga t1. valor pronóstico by Moyano Calvo, J.L., Ortiz Gámiz, A., Poyato Galán, J.M., Gutiérrez González, M., Sánchez Sánchez, E., Álvarez-Ossorio Fernández, J.L., Castiñeiras Fernández, J.

“…La permeación de los vasos linfáticos de la pared vesical (L+) es poco utilizada. 519 tumores T1, RTU completa y seguimiento mínimo de un año. Tratamiento…”
Get full text

The prevention of stage-T1 superficial bladder tumors with 27 mg. of BCG weekly over 6 weeks by Moyano Calvo, J L, Ortíz Gámiz, A, Romero Díaz, A, Sánchez Sánchez, E, Blanco Palenciano, E, Arribas Rodríguez, J M, Castiñeiras Fernández, J

“…To evaluate the utility of prophylactic treatment of stage T1 superficial tumors of the bladder with 27 mg BCG weekly for 6 weeks and to compare the results…”
Get more information